Singapore agetech – ones to watch in 2020

Latest articles

Exclusive: “Mitlets” hold potential for mitochondria transfusion

Mitrix Bio believes recently discovered blood components may support transfusion of large quantities of healthy mitochondria from donor to patient. Earlier this year, we brought...

Optimise your body and mind by tackling cell stress

Want to live longer and heathier? Combating cell stress is an important first step on your longevity journey. It's a fast-paced, busy world, and we're...

Crypto – pulling a (Moon) Rabbit out a hat for longevity

Angel Versetti on why it makes sense to look at more experimental solutions for longevity. Earlier this week we brought you part one of our...

New webinar will explore the opportunity of ovarian longevity

What does delaying menopause mean in terms of investment activity, societal change and the technologies that will reshape the lives of multiple millions of...

Most read

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Editor's picks

Exclusive: “Mitlets” hold potential for mitochondria transfusion

Mitrix Bio believes recently discovered blood components may support transfusion of large quantities of healthy mitochondria from donor to patient. Earlier this year, we brought...

Optimise your body and mind by tackling cell stress

Want to live longer and heathier? Combating cell stress is an important first step on your longevity journey. It's a fast-paced, busy world, and we're...

Crypto – pulling a (Moon) Rabbit out a hat for longevity

Angel Versetti on why it makes sense to look at more experimental solutions for longevity. Earlier this week we brought you part one of our...

Click the globe for translations.

Singapore thrives on its prime location at the crossroads of Asia’s biggest markets, low business tax and great IT infrastructure; it is well-positioned to become one of Agetech’s biggest players.

Longevity.Technology: Singapore is the poster-child for agetech; from community-centred models of elder care through to IoT wearables that offer cohesive diagnosis, treatment and monitoring and from preventative healthcare programmes to increased geriatric medicine staffing, its responsive approach to the Silver Tsunami is an enviable model.

Global populations are aging and this is particularly evident in Singapore, a country with one of the highest life expectancies in the world. Currently, one in eight Singaporeans is over 65, but by 2030, that will have rocketed to one in four; of these 960,000 over-65s, it is estimated that 92,000 of them will be living alone. The potential for Agetech to play a significant role in extending life and improving quality of life in Singapore is huge.

And the Singapore Government has realised this. The city-state’s size and economy has facilitated a progressive stance on Longevity, allowing initiative and development to flourish. In 2015, Singapore launched an action plan for aging well; among the measures are a range of preventative programmes that start at 40, the National Silver Academy, which offers educational programmes to the elderly and the Silver Generation Ambassadors, who provide home visits and make health services and government schemes more accessible.

In October 2016, Singapore Health Minister Gan Kim Yong announced that Singapore needs to “completely rethink the way it cares for the elderly [1],” moving this care out of hospitals and into the individuals’ homes and community.

In a landscape so switched-on to aging well, it is no surprise that Singapore has many companies and developments worth mentioning. The Aging Analytics Agency dedicated a report to Singapore’s Longevity economy and we have covered Biofourmis’ digital health biomarkers, as well as an in-depth interview (part 1 & part 2) with Brian Kennedy, Professor in the Department of Biochemistry and Physiology at the National University of Singapore, but here’s a round-up of some of the other agetech players in Singapore.


The Singapore Management University, in partnership with Tata Consultancy Services (SMU-TCS), has created the SHINESeniors Project – and it won the 9th annual SuperNova AI & Augmented Award last year. It aims to provide data-driven community care to seniors and “smart homes” for elderly people living on their own. Innovations include: smart sensors that monitor the environment and living patterns, alerting to changes in mobility or medication-taking; chairs fitted with sensors to prevent seniors from falling; and a dialysis-monitoring smartphone app that allows those suffering from kidney disease to measure and submit health data to clinicians and care givers.


One of the latest innovation from SMU-TCS is GERI, agetech that combines IoT, data analytics and a multimodal series of sensors to detect declining cognition and cognitive functions at those who are at-risk of developing dementia. The system allows periodic or continuous unobtrusive monitoring of at-risk Singaporeans. Still at the pilot study phase, SMU-TCS hopes the results will “inform further development of smart systems to assist with the assessment of cognitive and functional decline [2].”


Healthstats
Image from Healthstats

Using a proprietary algorithm, HealthstatsBPro wearable tech captures arterial pulse wave data, converting it into 24-hour ambulatory blood pressure readings. The wrist-worn agetech measures central aortic pressure, which has been shown to be the strongest predictor for strokes and heart attacks. With regulatory approval in more than twenty countries and BPro being used in more than twenty clinical trials, this practical, non-invasive device seems set for even more success.


According to Cornea Biosciences, “10,000,000 people in the world are blind in one or both eyes from corneal injury or disease,” but fewer than 150,000 corneal transplants are performed each year due a lack of donated corneas [3]. Cornea Biosciences plans to change those statistics with its bioengineered corneas. Made from type III recombinant human collagen cross-linked with biopolymers, the bioengineered corneas have undergone extensive biocompatability tests, including a four-year human clinical trial in Sweden.

Designed to work alongside existing patient tissue, which they supplement, rather than replace, the bioengineered corneas could “restore sight to millions of people who have suffered debilitating loss of vision due to corneal disease or injury.” Age-related blindness can be extremely isolating as well as life limiting, so a non-transplant dependent supply of corneas would be an important development in this area.


Senescence
Image from Senescence Life Sciences

Senescence Life Sciences‘ pharmaceutical division is focused on developing clinically-tested medicines for the prevention and treatment of Alzheimer’s disease. Currently in the pipeline is a multi-therapeutic that targets “cellular repair cycles upstream of β-Amyloid production”.  The first in-human trials are scheduled for the coming years.

Research into preventing, slowing and halting Alzheimer’s has become a top research priority. According to The Alzheimer’s Association, 1 in 3 older people will die from Alzheimer’s; this is more than breast and prostate cancer combined [4]. The costs of Alzheimer’s Disease are expected to spiral to more than $1.1 trillion by 2050 [5], so SLS’s new therapy could end up with some powerful supporters, as well as a strong pharma footprint.

Senescence Life Sciences’ nutraceutical division (SLS Nutraceuticals) also market an off-the-shelf range of nutraceuticals that (they claim) “improve brain health and increase cognitive performance”. Nutraceuticals are on the verge of becoming a booming business; after all, prevention is better – and cheaper – than cure.


NurAid
Image from NurAid

Moleac‘s NeuroAID II is designed to be a “therapy with multiple mechanisms of action” for victims of stroke, rather than a one-stop-shop. Strokes, which are estimated will be the cause of approximately 7·8 million deaths in 2030 and are a leading cause of acquired disability in adults [6] have a complex pathology. NeuroAID II, although only FDA-approved at Phase 1, has shown “additive and sustained benefits on post-stroke recovery over 2 years after an initial 3-month treatment following stroke onset [7].”

Given the numbers of stroke-related deaths, not to mention the costly and debilitating effects of surviving such a traumatic incident, we would hope that investment in stroke recovery therapies would prove an attractive proposition.

[1] https://bit.ly/37dxPoG
[2] https://icity.smu.edu.sg/node/1426
[3] https://www.corneabio.com/
[4] https://www.alz.org/alzheimers-dementia/facts-figures
[5] https://www.ncbi.nlm.nih.gov/pubmed/22214393
[6] https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1747-4949.2012.00969.x
[7] https://bit.ly/2RGcKwL

Image credit: Swapnil Bapat / Unsplash
Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

Most popular

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Related articles

Crypto – pulling a (Moon) Rabbit out a hat for longevity

Angel Versetti on why it makes sense to look at more experimental solutions for longevity. Earlier this week we brought you part one of our...

New webinar will explore the opportunity of ovarian longevity

What does delaying menopause mean in terms of investment activity, societal change and the technologies that will reshape the lives of multiple millions of...

Buck Institute awarded $12.7m to join senescence network

NIH award to join SenNet, the Cellular Senescence Network, will enable Buck scientists to identify and characterise senescent cells – recognised as a driver...

Michael Antonov: longevity is all about tackling true unknowns

The Co-founder of Formic Ventures is using logic and innovation to drive the longevity sector forward. Michael Antonov is a serial entrepreneur and philanthropist who...

Shooting for the moon means going down the rabbit hole

Scientific co-operation, research collaboration and alternative financial incentives – Moon Rabbit is a crypto-conglomerate on a longevity mission. Moon Rabbit is on a mission to...